What Is A Zantac OTC Lawsuit?

One of the main types of ranitidine drugs that have been withdrawn due to cancer risk is Zantac – both prescription and over-the-counter (OTC). Zantac's over-the-counter claim is a legal claim for financial compensation for patients who have taken Zantac without a prescription and later developed cancer. The patient has filed lawsuits via https://zantacantacidcancerlawsuit.com/heartburn-medicine-cancer.asp against Sanofi, the maker of the drug Zantac, and other ranitidine manufacturers.

Zantac and other drugs for ranitidine belong to the group of drugs that block histamine-2. This medication is designed to reduce the amount of acid produced by a person's stomach. Therefore, OTC Zantac, Prescription Zantac, and other generic ranitidine are used to treat heartburn caused by gastroesophageal reflux disease (GERD) and to prevent and treat ulcers.

John Bales Attorneys

Image Source: Google

How dangerous is NDMA for Zantac OTC patients?

According to the US Food and Drug Administration (FDA), NDMA has been found in different classes of ranitidine products, including OTC Zantac, and the presence of this contaminant grows over time. If a patient takes Zantac or another ranitidine product containing NDMA, this user may be exposed to "unacceptable" levels of the contaminant. 

The FDA states that NDMA is "likely to cause cancer" meaning "a substance that can cause cancer". OTC Zantac and other ranitidine products have been linked to a variety of cancers, including but not limited to the following:

  • Bladder cancer
  • Blood cancer
  • Breast cancer
  • Colon cancer
  • Stomach cancer
  • Heart cancer
  • Lung cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Kidney cancer
  • Stomach cancer
  • Thyroid cancer
  • Cervical cancer.